According to the AHA – 1.5 million in the US suffer from Aortic Stenosis. Aortic valve stenosis (AS) is a complex disease caused by a narrowing or hardening of the aortic valve due to calcium buildup on the heart valve flaps.
Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis and is being performed for growing numbers of patients. It is estimated that > 250,000 TAVI procedures are performed globally each year.
Currently 25% of patients are unable to undergo TAVI procedure due to higher associated risks and complications from specific anatomical quirks.
The orifice of the two coronaries (the arteries that supply blood to the heart muscle,
are located behind the leaflets of the Aortic valve. There is an immediate risk of obstruction of the blood flow into the coronaries if the cusps of the replaced valve are pushed by the new implant.
This obstruction will immediately compromise the heart function placing the life of these patients at an instant and clear danger.
HVT Medical’s Splitter device performs cusp splitting before a TAVI procedure, to help reduce risk of coronary occlusion.
The device creates an intentional laceration or excision of valve’s cusp tissue by applying an advanced catheter equipped with cutting head that mimics an alligator jaw.
The catheter rides a standard guide wire for TAVI operations so the splitter will be integrated completely into the workflow of the valve implementation.